- Patent Title: Eye disease treatment agent, screening method therefor, and method for predicting rejection response associated with retinal pigment epithelial cell transplant
-
Application No.: US15120433Application Date: 2015-02-20
-
Publication No.: US10240201B2Publication Date: 2019-03-26
- Inventor: Masayo Takahashi , Sunao Sugita
- Applicant: Healios K.K.
- Applicant Address: JP Tokyo
- Assignee: Healios K.K.
- Current Assignee: Healios K.K.
- Current Assignee Address: JP Tokyo
- Agency: Mintz Levin Cohn Ferris Glovsky and Popeo, P.C.
- Priority: JP2014-032325 20140221
- International Application: PCT/JP2015/054871 WO 20150220
- International Announcement: WO2015/125941 WO 20150827
- Main IPC: C12Q1/6883
- IPC: C12Q1/6883 ; A61K35/30 ; G01N33/68 ; A61L27/36
Abstract:
The present invention provides an agent for treating ophthalmic diseases and a screening method for an agent for treating ophthalmic diseases and the like. The present invention also provides a method for predicting rejection associated with transplantation of retinal pigment epithelial cell to patients with ophthalmic diseases.
Public/Granted literature
Information query
